Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Clinical trial NCT06927635 · RECRUITING

Trial details

NCT number: NCT06927635
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castrate Resistance Prostate Cancer OligoProgressive Metastatic Disease

Start date: 2025-07-08
Primary completion: 2030-06-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.